Cart
sales@molnova.com
KRAS G12C inhibitor 19
CAS No. 2649788-46-3
KRAS G12C inhibitor 19( —— )
Catalog No. M35195 CAS No. 2649788-46-3
KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that demonstrates anti-tumor activity in cellular assays and inhibits tumor growth .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 126 | Get Quote |
|
| 5MG | 186 | Get Quote |
|
| 10MG | 280 | Get Quote |
|
| 25MG | 526 | Get Quote |
|
| 50MG | 753 | Get Quote |
|
| 100MG | 1017 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKRAS G12C inhibitor 19
-
NoteResearch use only, not for human use.
-
Brief DescriptionKRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that demonstrates anti-tumor activity in cellular assays and inhibits tumor growth .
-
DescriptionKRAS G12C inhibitor 19 is a potent inhibitor of KRAS G12C. KRAS G12C inhibitor 19 significantly inhibits tumor growth (extracted from patent WO2021118877A1).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorKras
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2649788-46-3
-
Formula Weight528.96
-
Molecular FormulaC25H19ClF2N4O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (236.31 mM; Ultrasonic )
-
SMILESC(#N)C=1C2=C(C=CC(F)=C2SC1N)C=3C(Cl)=C4C(=CC3F)C(=O)N5[C@@](CCO4)(CN(C(C=C)=O)CC5)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Serge Louis Boulet, et al. Kras g12c inhibitors. Patent WO2021118877A1.
molnova catalog
related products
-
Bathophenanthroline
Bathophenanthroline is a compound used for the measurement of iron concentrations in aqueous, urine, and serum samples by colorimetry.
-
Thymocartin
Thymocartin (RGH 0206) is a fragment 32-35 of the naturally occurring thymic factor (thymopoietin).Thymocartin is used in the study of immunodeficiency diseases.
-
Garetosmab
Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44.
